Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes

确定 1 型糖尿病中 IFIH1 疾病相关变异对 β 细胞和免疫反应的机制

基本信息

  • 批准号:
    10903049
  • 负责人:
  • 金额:
    $ 119.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Type 1 diabetes (T1D) is a multifactorial autoimmune disease that requires genetic susceptibility as well as environmental triggers such as viral infections in triggering disease onset. One viral infection that is highly correlated with T1D is the Coxsackievirus B (CVB) serotype. Sensing of CVB is mediated by the melanoma differentiation-associated protein 5 (MDA5), a cytosolic sensor of dsRNA, which is encoded by the IFIH1 gene. Stimulation of the MDA5 signaling pathway activates the transcription factors IRF3 and NF-κB p65, which induce Type I IFNs synthesis, which through autocrine signaling initiate an antiviral transcriptional program. Single nucleotide polymorphisms (SNPs) in the IFIH1 gene such as rs1990760, which results in a non-synonymous mutation that changes alanine at position 946 to a threonine, is highly associated with increased risk for T1D. Studies in human PBMCs and mice have demonstrated that the A946T SNP results in an increased sensitivity to viral ligands and subsequently a stronger downstream IFN response. Macrophages have been shown previously to play an important role in T1D initiation, however, the response of β-cells to viral infection is also important. Our central hypothesis is that T1D-associated SNPs result in an exacerbated islet-resident macrophage immune response and β-cell inflammatory response following CVB3 infection which contributes to the initiation of autoimmunity. This will be tested using monocyte- derived macrophages and dendritic cells and induced pluripotent stem cells engineered to become human pancreatic β-cells from healthy donors and patients with T1D that are genotyped for IFIH1 SNPs that contribute to T1D susceptibility and resistance.
项目总结/摘要 1型糖尿病(T1 D)是一种多因素自身免疫性疾病,需要遗传易感性, 以及病毒感染等环境触发因素引发疾病发作。1例病毒感染 与T1 D高度相关的是柯萨奇病毒B(CVB)血清型。感知CVB是 由黑素瘤分化相关蛋白5(MDA 5)介导,所述MDA 5是dsRNA的胞质传感器, 由IFIH 1基因编码。刺激MDA 5信号通路激活了 转录因子IRF 3和NF-κB p65,它们诱导I型IFN的合成, 自分泌信号启动抗病毒转录程序。单核苷酸多态性 IFIH 1基因中的SNP,如rs 1990760,其导致非同义突变, 将946位的丙氨酸变为苏氨酸,与T1 D风险增加高度相关。 在人PBMC和小鼠中的研究已经证明,A946 T SNP导致增加的细胞增殖。 对病毒配体的敏感性和随后更强的下游IFN应答。巨噬细胞具有 先前已显示在T1 D起始中起重要作用,然而,β细胞对 病毒感染也很重要。我们的中心假设是T1 D相关的SNP导致 胰岛驻留巨噬细胞免疫反应和β细胞炎症反应加剧, CVB 3感染,导致自身免疫的启动。这将用单核细胞进行测试- 衍生的巨噬细胞和树突细胞以及诱导的多能干细胞, 来自健康供体和T1 D患者的人胰腺β细胞,其针对IFIH 1进行基因分型 导致T1 D易感性和耐药性的SNP。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLAYTON E MATHEWS其他文献

CLAYTON E MATHEWS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLAYTON E MATHEWS', 18)}}的其他基金

Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
原位胰岛新抗原在人类 1 型糖尿病中的发现及其作用
  • 批准号:
    10589578
  • 财政年份:
    2023
  • 资助金额:
    $ 119.25万
  • 项目类别:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
确定 1 型糖尿病中 IFIH1 疾病相关变异对 β 细胞和免疫反应的机制
  • 批准号:
    10417267
  • 财政年份:
    2020
  • 资助金额:
    $ 119.25万
  • 项目类别:
Organ Specific Project
器官特定项目
  • 批准号:
    10685591
  • 财政年份:
    2020
  • 资助金额:
    $ 119.25万
  • 项目类别:
Organ Specific Project
器官特定项目
  • 批准号:
    10259784
  • 财政年份:
    2020
  • 资助金额:
    $ 119.25万
  • 项目类别:
Organ Specific Project
器官特定项目
  • 批准号:
    10118877
  • 财政年份:
    2020
  • 资助金额:
    $ 119.25万
  • 项目类别:
Multi-omic 3D tissue maps for a Human BioMolecular Atlas
人类生物分子图谱的多组学 3D 组织图谱
  • 批准号:
    10649957
  • 财政年份:
    2020
  • 资助金额:
    $ 119.25万
  • 项目类别:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
确定 1 型糖尿病中 IFIH1 疾病相关变异对 β 细胞和免疫反应的机制
  • 批准号:
    10263321
  • 财政年份:
    2020
  • 资助金额:
    $ 119.25万
  • 项目类别:
Genetic Regulation of Human Beta Cell Destruction
人类β细胞破坏的基因调控
  • 批准号:
    8813679
  • 财政年份:
    2014
  • 资助金额:
    $ 119.25万
  • 项目类别:
mt-Nd2 and Resistance to Autoimmune Diabetes
mt-Nd2 与自身免疫性糖尿病的抵抗力
  • 批准号:
    7998873
  • 财政年份:
    2010
  • 资助金额:
    $ 119.25万
  • 项目类别:
mt-Nd2 and Resistance to Autoimmune Diabetes
mt-Nd2 与自身免疫性糖尿病的抵抗力
  • 批准号:
    8297271
  • 财政年份:
    2006
  • 资助金额:
    $ 119.25万
  • 项目类别:

相似海外基金

SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Standard Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
  • 批准号:
    2307983
  • 财政年份:
    2023
  • 资助金额:
    $ 119.25万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了